These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9744032)

  • 21. [Isolation and identification in Senegal of the most immunogenic protein soluble antigen of a Clostridium chauvoei strain].
    Mbengue MB
    Bull Soc Pathol Exot; 2008 Feb; 101(1):3-4. PubMed ID: 18431995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular specificities of antibodies against ovine and murine recombinant prion proteins.
    Betemps D; Baron T
    Biochem Biophys Res Commun; 2001 Feb; 281(1):101-8. PubMed ID: 11178966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunogenicity and protection of divalent DNA vaccine encoding antigens MPT83 and MPT64 of Mycobacterium tuberculosis].
    Tian X; Cai H; Zhu YX
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1410-3. PubMed ID: 16029655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant peptides as immunogens: a comparison of protocols for antisera production using the pGEX system.
    Oettinger HF; Pasqualini R; Bernfield M
    Biotechniques; 1992 Apr; 12(4):544-9. PubMed ID: 1503757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycobacterium tuberculosis secreting protein Ag85B-ESAT6 fused expression and purification].
    Shi CH; Fan XL; Xu ZK; Li Y; Bai YL; Xue Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):89-92. PubMed ID: 14990181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of mucosal immune response following oral administration of enterotoxigenic Escherichia coli fimbriae (CFA/I) entrapped in liposomes in conjunction with inactivated whole-cell Vibrio cholerae vaccine.
    Dima VF; Ionescu MD; Palade R; Balotescu C; Becheanu G; Dima SV
    Roum Arch Microbiol Immunol; 2001; 60(1):27-54. PubMed ID: 11850896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional expression of Bacillus anthracis protective antigen in E. coli.
    Vahedi F; Sankian M; Mahmoudi M
    Appl Biochem Biotechnol; 2009 Jun; 157(3):554-61. PubMed ID: 18654743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recombinant plasmid constructed and cytotoxicity studied for outer membrane protein LipL32 gene of Leptospira strain 017].
    Huang B; Bao L; Zhong Q; Shang ZL; Zhang HD; Wang ZP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):347-50. PubMed ID: 18575312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the recombinant 38-kDa antigen of Mycobacterium tuberculosis as an immunogen for specific antisera production.
    D'Souza CD; Kadival GV; Samuel AM
    Microbiol Immunol; 1994; 38(10):797-800. PubMed ID: 7869957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New flow cytometric method to quantify the inhibition of enteropathogenic Escherichia coli adhesion by anti-adhesin antibodies.
    Boullier S; Tasca C; Milon A
    Cytometry A; 2003 Jun; 53(2):79-87. PubMed ID: 12766969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolation and study of the properties of the hemagglutinins produced by Streptomyces badius actinomycetes].
    Beliaev OA; Grinberg GE; Konev IuE; Dubovenko LL; Mikhaĭlets GA
    Prikl Biokhim Mikrobiol; 1985; 21(3):372-7. PubMed ID: 3900977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of a monoclonal antibody to the TrpE protein and its use for the purification of recombinant fusion proteins.
    Nurse F; Dagan S; Tackney C; Goldstein NI
    Hybridoma; 1991 Dec; 10(6):753-60. PubMed ID: 1816074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitation of E. coli protein impurities in recombinant human interferon-gamma.
    Chen AB; Championsmith AA; Blanchard J; Gorrell J; Niepelt BA; Federici MM; Formento J; Sinicropi DV
    Appl Biochem Biotechnol; 1992 Aug; 36(2):137-52. PubMed ID: 1444359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic competition in the immune response against protein mixtures: strain-specific non-immunogenicity of Escherichia coli antigens.
    Hammerl P; Weger R; Thalhamer J
    Mol Immunol; 1988 Mar; 25(3):313-20. PubMed ID: 3287142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expeditious screening of candidate proteins for microbial vaccines.
    Zaheer R; Klima CL; McAllister TA
    J Microbiol Methods; 2015 Sep; 116():53-9. PubMed ID: 26149626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escherichia coli as a biologically active ingredient of suppositories. Solid phase extraction and quantification in a double antibody ELISA.
    Barthold E; Bayer M; Maasch HJ
    Arzneimittelforschung; 1994 Jan; 44(1):102-8. PubMed ID: 8135872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization procedures for E. coli proteins.
    Anicetti VR; Simonetti MA; Blackwood LL; Jones AJ; Chen AB
    Appl Biochem Biotechnol; 1989 Nov; 22(2):151-68. PubMed ID: 2692518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and quantitative determination of antibodies against major outer mambranes proteins of Escherichia coli O26 K60.
    Hofstra H; Dankert J
    J Gen Microbiol; 1980 Apr; 117(2):437-47. PubMed ID: 6775043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple method for the preparation of high titre antisera to Salmonella and Escherichia coli.
    Aleksic V; Rohde R; Aleksic S
    Ann Microbiol (Paris); 1973 Dec; 124(4):587-90. PubMed ID: 4599960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.